Table 3 summarizes the demographics of the participants with DS and sibling controls at their baseline visit, including sex, age, karyotype, APOE status, co‐occurring medical conditions, and clinical AD status at the first consensus conference. This evidence concerns the gene APOE and Alzheimer disease.